SOLENO THERAPEUTICS INC
Rank #219HypergrowthSLNO
SOLENO THERAPEUTICS INC (SLNO) — Rank #219 by gross profitability (GP/assets 0.31) · ROE 4.2% · Piotroski F-Score N/A.
As-of 2026-09-15 · CIK 0001484565 · all metrics point-in-time as of the filing date.
About
- State
- DE
- Filer Category
- Large accelerated filer
- Fiscal Year End
- December 31
Financials
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2016-12-31filed 2017-03-15 | 2015-12-31filed 2016-03-25 | 2014-12-31filed 2016-03-25 | 2013-12-31filed 2015-03-13 |
|---|---|---|---|---|
| Assets | ||||
| Cash & equivalents | 2.7 | 5.5 | 8.0 | 1.3 |
| Accounts receivable | 0.1 | 0.2 | 0.0 | 0.1 |
| Inventory | 0.7 | 0.6 | 0.1 | — |
| Total current assets | 3.8 | 6.4 | 8.3 | 1.5 |
| Property, plant & equipment, net | 0.1 | 0.1 | 0.1 | 0.1 |
| Goodwill | 0.8 | 0.9 | 0.0 | — |
| Total assets | 5.6 | 8.2 | 8.4 | 1.6 |
| Liabilities | ||||
| Accounts payable | 0.5 | 0.7 | 1.0 | 0.1 |
| Total current liabilities | 1.7 | 3.2 | 1.3 | 14.2 |
| Total liabilities | 2.1 | — | — | — |
| Equity | ||||
| Retained earnings | (98.3) | (86.2) | (70.3) | (57.1) |
| Total shareholders' equity | 3.4 | 3.2 | (11.2) | (37.9) |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?